Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

Patterns of herpes simplex virus shedding over 1 month and the impact of acyclovir and HIV in HSV-2-seropositive women in Tanzania.

Tanton C, Weiss HA, LeGoff J, Changalucha J, Clayton TC, Ross DA, Belec L, Hayes RJ, Watson-Jones D.

Sex Transm Infect. 2011 Aug;87(5):406-11. doi: 10.1136/sti.2010.048496. Epub 2011 Jun 8.

PMID:
21653932
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers.

Cowan FM, Pascoe SJ, Barlow KL, Langhaug LF, Jaffar S, Hargrove JW, Robinson NJ, Bassett MT, Wilson D, Brown DW, Hayes RJ.

Sex Transm Infect. 2008 Dec;84(7):548-53. doi: 10.1136/sti.2008.031153. Epub 2008 Aug 6.

PMID:
18684855
[PubMed - indexed for MEDLINE]
3.

Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.

Gupta R, Wald A, Krantz E, Selke S, Warren T, Vargas-Cortes M, Miller G, Corey L.

J Infect Dis. 2004 Oct 15;190(8):1374-81. Epub 2004 Sep 20.

PMID:
15378428
[PubMed - indexed for MEDLINE]
Free Article
4.

Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.

Wald A, Zeh J, Barnum G, Davis LG, Corey L.

Ann Intern Med. 1996 Jan 1;124(1 Pt 1):8-15.

PMID:
7503497
[PubMed - indexed for MEDLINE]
5.

Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa.

Delany S, Mlaba N, Clayton T, Akpomiemie G, Capovilla A, Legoff J, Belec L, Stevens W, Rees H, Mayaud P.

AIDS. 2009 Feb 20;23(4):461-9. doi: 10.1097/QAD.0b013e32831db217.

PMID:
19155993
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes.

LeGoff J, Weiss HA, Gresenguet G, Nzambi K, Frost E, Hayes RJ, Mabey DC, Malkin JE, Mayaud P, Belec L.

AIDS. 2007 Jul 31;21(12):1569-78.

PMID:
17630552
[PubMed - indexed for MEDLINE]
7.

High-dose valacyclovir decreases plasma HIV-1 RNA more than standard-dose acyclovir in persons coinfected with HIV-1 and HSV-2: a randomized crossover trial.

Perti T, Saracino M, Baeten JM, Johnston C, Diem K, Ocbamichael N, Huang ML, Selke S, Magaret A, Corey L, Wald A.

J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):201-8. doi: 10.1097/QAI.0b013e3182928eea.

PMID:
23542637
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.

Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J.

J Clin Invest. 1997 Mar 1;99(5):1092-7.

PMID:
9062368
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Effect of HSV-2 suppressive therapy on genital tract HIV-1 RNA shedding among women on HAART: a pilot randomized controlled trial.

Nijhawan AE, Delong AK, Chapman S, Rana A, Kurpewski J, Ingersoll J, Caliendo AM, Cu-Uvin S.

Infect Dis Obstet Gynecol. 2012;2012:868526. doi: 10.1155/2012/868526. Epub 2012 Feb 28.

PMID:
22505800
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.

Sperling RS, Fife KH, Warren TJ, Dix LP, Brennan CA.

Sex Transm Dis. 2008 Mar;35(3):286-90.

PMID:
18157071
[PubMed - indexed for MEDLINE]
11.

Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial.

Mayaud P, Legoff J, Weiss HA, Grésenguet G, Nzambi K, Bouhlal H, Frost E, Pépin J, Malkin JE, Hayes RJ, Mabey DC, Bélec L; ANRS 1212 Study Group.

J Infect Dis. 2009 Jul 15;200(2):216-26. doi: 10.1086/599991.

PMID:
19530940
[PubMed - indexed for MEDLINE]
Free Article
12.

Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial.

Tanton C, Weiss HA, Rusizoka M, Legoff J, Changalucha J, Baisley K, Mugeye K, Everett D, Belec L, Clayton TC, Ross DA, Hayes RJ, Watson-Jones D.

J Infect Dis. 2010 May 1;201(9):1285-97. doi: 10.1086/651696.

PMID:
20235836
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus.

Nagot N, Ouédraogo A, Foulongne V, Konaté I, Weiss HA, Vergne L, Defer MC, Djagbaré D, Sanon A, Andonaba JB, Becquart P, Segondy M, Vallo R, Sawadogo A, Van de Perre P, Mayaud P; ANRS 1285 Study Group.

N Engl J Med. 2007 Feb 22;356(8):790-9.

PMID:
17314338
[PubMed - indexed for MEDLINE]
Free Article
14.

Clinical and virologic response to episodic acyclovir for genital ulcers among HIV-1 seronegative, herpes simplex virus type 2 seropositive African women: a randomized, placebo-controlled trial.

Baeten JM, Reid SE, Delany-Moretlwe S, Hughes JP, Wang RS, Wilcox E, Limbada M, Akpomiemie G, Corey L, Wald A, Celum C.

Sex Transm Dis. 2012 Jan;39(1):21-4. doi: 10.1097/OLQ.0b013e31823b50c6.

PMID:
22183840
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai, Thailand.

Dunne EF, Whitehead S, Sternberg M, Thepamnuay S, Leelawiwat W, McNicholl JM, Sumanapun S, Tappero JW, Siriprapasiri T, Markowitz L.

J Acquir Immune Defic Syndr. 2008 Sep 1;49(1):77-83. doi: 10.1097/QAI.0b013e3181831832.

PMID:
18667923
[PubMed - indexed for MEDLINE]
16.

Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.

Fife KH, Warren TJ, Ferrera RD, Young DG, Justus SE, Heitman CK, Burroughs SM.

Mayo Clin Proc. 2006 Oct;81(10):1321-7.

PMID:
17036557
[PubMed - indexed for MEDLINE]
17.

Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.

Watson-Jones D, Weiss HA, Rusizoka M, Changalucha J, Baisley K, Mugeye K, Tanton C, Ross D, Everett D, Clayton T, Balira R, Knight L, Hambleton I, Le Goff J, Belec L, Hayes R; HSV trial team; Steering and Data Monitoring Committees.

N Engl J Med. 2008 Apr 10;358(15):1560-71. doi: 10.1056/NEJMoa0800260. Epub 2008 Mar 12. Erratum in: N Engl J Med. 2010 Apr 15;362(15):1450.

PMID:
18337596
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial.

Paz-Bailey G, Sternberg M, Puren AJ, Markowitz LE, Ballard R, Delany S, Hawkes S, Nwanyanwu O, Ryan C, Lewis DA.

J Infect Dis. 2009 Oct 1;200(7):1039-49. doi: 10.1086/605647.

PMID:
19715417
[PubMed - indexed for MEDLINE]
Free Article
19.

Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial.

Fuchs J, Celum C, Wang J, Hughes J, Sanchez J, Cowan F, Reid S, Delany-Moretlwe S, Corey L, Wald A; HIV Prevention Trials Network 039 Protocol Team.

J Infect Dis. 2010 Apr 15;201(8):1164-8. doi: 10.1086/651381.

PMID:
20214474
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.

Johnston C, Saracino M, Kuntz S, Magaret A, Selke S, Huang ML, Schiffer JT, Koelle DM, Corey L, Wald A.

Lancet. 2012 Feb 18;379(9816):641-7. doi: 10.1016/S0140-6736(11)61750-9. Epub 2012 Jan 4. Erratum in: Lancet. 2012 Feb 18;379(9816):616.

PMID:
22225814
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk